Back to Search
Start Over
αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?
- Source :
- Repositório Científico de Acesso Aberto de Portugal, Repositório Científico de Acesso Aberto de Portugal (RCAAP), instacron:RCAAP
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- Integrins are cell adhesion receptors predominantly important during normal and tumor angiogenesis. A sequence present on several extracellular matrix proteins composed of Arg-Gly-Asp (RGD) has attracted attention due to its role in cell adhesion mediated by integrins. The development of ligands that can bind to integrins involved in tumor angiogenesis and brake disease progression has resulted in new investigational drug entities reaching the clinical trial phase in humans. The use of integrin-specific ligands can be useful for the vascularization of regenerative medicine constructs, which remains a major limitation for translation into clinical practice. In order to enhance vascularization, immobilization of integrin-specific RGD peptidomimetics within constructs is a recommended approach, due to their high specificity and selectivity towards certain desired integrins. This review endeavours to address the potential of peptidomimetic-coated biomaterials as vascular network promoters for regenerative medicine purposes. Clinical studies involving molecules tracking active integrins in cancer angiogenesis and reasons for their failure are also addressed.<br />Prémios Santa Casa Neurociências - Prize Melo e Castro for Spinal Cord Injury Research; Portuguese Foundation for Science and Technology [Doctoral fellowship (PD/BDE/127835/2016) to L. A. Rocha; IF Development Grant to A. J. Salgado; national funds through grant TUBITAK/0007/2014]. This article has been developed under the scope of the projects NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER); This work has been funded by FEDER funds, through the Competitiveness Factors Operational Programme (COMPETE), and by National funds, through the Foundation for Science and Technology (FCT), under the scope of the project POCI-01-0145-FEDER-007038<br />info:eu-repo/semantics/publishedVersion
- Subjects :
- 0301 basic medicine
Integrins
Peptidomimetic
Angiogenesis
Medicina Básica [Ciências Médicas]
Integrin
Angiogenesis Inhibitors
Bioengineering
Applied Microbiology and Biotechnology
Regenerative medicine
Biomaterials
Extracellular matrix
Mice
03 medical and health sciences
Tissue engineering
Drug Discovery
Animals
Humans
Cell adhesion
Integrin alphaVbeta3
Science & Technology
Neovascularization, Pathologic
biology
Drug discovery
Vascularization
3. Good health
030104 developmental biology
Ciências Médicas::Medicina Básica
Immunology
biology.protein
Cancer research
Integrin alpha5beta1
Biotechnology
Subjects
Details
- ISSN :
- 07349750
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Biotechnology Advances
- Accession number :
- edsair.doi.dedup.....8da584fcbe7473aae38031242ff0933f
- Full Text :
- https://doi.org/10.1016/j.biotechadv.2017.11.004